||Methylprodnisolone Sodium Succinate
||METHYLPREDNISOLONE, a water-soluble ester, is used for allergic, cardiac, and hypoxic emergencies.
||GLP-1 receptor agonist 1
||GLP-1 receptor agonist 1 is a GLP-1 receptor agonist .
||PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
||Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment.
||Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).
||GRA-Ex-25 is an inhibitor of glucagon receptor.
||Shanzhiside methyl ester
||Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
||Exendin-4 is a glucagon-like peptide-1 receptor (GLP-1) agonist (IC50: 3.22 nM). Exenatide is a 39 amino acid peptide. Compared to GLP-1, exenatide has a longer half-life of 2.4 ho
||GLP-1 (7-36) amide is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic ef
||Liraglutide is a long-acting GLP-1 receptor agonist.
||NNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
||Exendin-4 acetate is a 39 amino acid peptide.Exendin-4 acetate is a long-acting GLP-1 receptor agonist(IC50 = 3.22 nM).
||PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
||HAEGTFT acetate(926018-95-3 free base)
||HAEGTFT acetate is the first N-terminal 1-7 residues of GLP-1 peptide.
||HAEGTFTSD acetate(926018-45-3 free base)
||HAEGTFTSD acetate is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, i
||Lixisenatide acetate (320367-13-3 free base)
||Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM).
||Albiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).
||BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).
||PF-06291874 (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor.